雪兰诺是欧洲最大的生物技术公司，它的米托蒽醌和利比（Rebif）是其开发的治疗多发性硬化病的重要产品。
基于442个网页-相关网页
在PRIS多发性硬化症实验中观察了两种利比干扰素（Rebif）剂量（44ug和22ug）每周3次治疗多发性硬化症结果高剂量疗效明显好于低剂量；比较每周1次应用66ug利比干扰素（Rebif）和每周3次（...
基于40个网页-相关网页
Biogen's only drug, the multiple sclerosis fighter Avonex, is under heavy fire from Serono's Rebif.
FORBES: Skin Deep
Additionally, adverse events like diarrhea, hair thinning and back pain were more common in patients treated with Rebif.
FORBES: European Pharma Stocks Hit on Bad News
There's a new competing drug just out called Rebif from Swiss biotech outfit Serono, which has teamed up with pharmaceutical marketing powerhouse Pfizer.
FORBES: Biopipeline
应用推荐
模块上移
模块下移
不移动